Results 241 to 250 of about 91,755 (270)
Some of the next articles are maybe not open access.
Open-Label Phase II Study of the Efficacy of Nivolumab for Cancer of Unknown Primary
Annals of Oncology, 2022Shin Takahashi, Y Takiguchi, J Tanizaki
exaly
Open-Label Phase II Study of the Efficacy of Nivolumab for Cancer of Unknown Primary
Annals of Oncology, 2022